DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Emcure Pharmaceuticals Limited — Shareholders meeting

NSE 2d ago·28 Aug 2026, 3:31 pm

Emcure Pharmaceuticals

Emcure Pharmaceuticals has announced that its Annual General Meeting (AGM) is scheduled for September 21, 2026. This formal notice confirms the date for the company's annual gathering of shareholders to approve financial statements and elect directors.

For investors, this meeting is a key milestone that signals the company's governance cycle. It provides a scheduled opportunity for the board to communicate strategy and for shareholders to exercise their voting rights on corporate matters.

Investors should monitor the company's official filings for updates on agenda items and resolutions. This meeting is a routine corporate event, but it offers a chance to review the company's upcoming plans and governance structure.